| 臺大學術典藏 |
2022-06-20T05:27:03Z |
Correction: FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
|
SHENG-KAI LIANG; Hsu, Chia-Chan; Song, Hsiang-Lin; Huang, Yu-Chi; Kuo, Chun-Wei; Yao, Xiang; Li, Chien-Cheng; Yang, Hui-Chen; Hung, Yu-Ling; Chao, Sheng-Yang; Wu, Shun-Chi; Tsai, Feng-Ren; Chen, Jen-Kun; Liao, Wei-Neng; Cheng, Shih-Chin; Tsou, Tsui-Chun; Wang, I-Ching |
| 臺大學術典藏 |
2022-06-20T05:26:13Z |
Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers
|
SHENG-KAI LIANG; Chien, Li-Hsin; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Chen, Yuh-Min; Huang, Ming-Shyan; Lin, Hsien-Chih; Fang, Wen-Tsen; Hung, Hsiao-Han; Jiang, Shih-Sheng; Chen, Chih-Yi; Chen, Kuan-Yu; Chang, I-Shou; Hsiung, Chao A; Chen, Chien-Jen; Yang, Pan-Chyr |
| 臺大學術典藏 |
2021-10-21T23:28:02Z |
Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers
|
SHENG-KAI LIANG; Chien, Li Hsin; Chang, Gee Chen; Tsai, Ying Huang; Su, Wu Chou; Chen, Yuh Min; Huang, Ming Shyan; Lin, Hsien Chih; Fang, Wen Tsen; Hung, Hsiao Han; Jiang, Shih Sheng; CHIH-YI CHEN; Chen, Kuan Yu; Chang, I. Shou; Hsiung, Chao A.; Chen, Chien Jen; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-10-21T23:28:00Z |
Correction: FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis (Oncogene, (2021), 40, 30, (4847-4858), 10.1038/s41388-021-01895-2)
|
SHENG-KAI LIANG; Hsu, Chia Chan; HSIANG-LIN SONG; Huang, Yu Chi; CHUN-WEI KUO; Yao, Xiang; Li, Chien Cheng; Yang, Hui Chen; Hung, Yu Ling; Chao, Sheng Yang; Wu, Shun Chi; Tsai, Feng Ren; Chen, Jen Kun; Liao, Wei Neng; Cheng, Shih Chin; Tsou, Tsui Chun; Wang, I. Ching |
| 臺大學術典藏 |
2021-09-17T03:21:21Z |
Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii)
|
Lee M.-R.; Tsai H.-Y.; Cheng A.; Liu C.-Y.; Huang Y.-T.; Liao C.-H.; SHENG-KAI LIANG; Lee L.-N.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T03:21:21Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
Lee M.-R.; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; SHENG-KAI LIANG; Liao C.-H.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T03:21:20Z |
Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy
|
Keng L.-T.; Shu C.-C.; Chen J.Y.P.; SHENG-KAI LIANG; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-09-17T03:21:20Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
Lee M.-R.; Ko J.-C.; SHENG-KAI LIANG; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T03:21:20Z |
Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014
|
Lee M.-R.; Tsai C.-J.; SHENG-KAI LIANG; Lin C.-K.; Huang Y.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T03:21:19Z |
Bronchial atresia
|
Keng L.-T.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-09-17T03:21:19Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; Ko J.-C.; SHENG-KAI LIANG; Liang M.-C. |
| 臺大學術典藏 |
2021-09-17T03:21:19Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
SHENG-KAI LIANG; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:18Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
SHENG-KAI LIANG; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:18Z |
Foxm1 Transcription Factor Regulates Lung Adenocarcinoma Development
|
SHENG-KAI LIANG; Chao S.-Y.; Li C.-C.; Ip K.-U.; Lin Y.-K.; Hsu C.-C.; Hsu P.-C.; Wang I.-C. |
| 臺大學術典藏 |
2021-09-17T03:21:18Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Keng L.-T.; Chung K.-P.; Lin S.-Y.; SHENG-KAI LIANG; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T03:21:17Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
SHENG-KAI LIANG; Ko J.-C.; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:17Z |
Albers-Sch?nberg disease
|
Keng L.-T.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-09-17T03:21:16Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; SHENG-KAI LIANG; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Liu C.-J.; Keng L.-T.; Lee M.-R.; Ko J.-C.; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-17T03:21:16Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T03:21:16Z |
Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model
|
Chien L.-H.; Chen C.-H.; Chen T.-Y.; Chang G.-C.; Tsai Y.-H.; Hsiao C.-F.; Chen K.-Y.; Su W.-C.; Wang W.-C.; Huang M.-S.; Chen Y.-M.; Chen C.-Y.; SHENG-KAI LIANG; Chen C.-Y.; Wang C.-L.; Lee M.-H.; Chung R.-H.; Tsai F.-Y.; Hu J.-W.; Katki H.A.; Chatterjee N.; Chanock S.J.; Rothman N.; Lan Q.; Yang P.-C.; Chen C.-J.; Chang I.-S.; Hsiung C.A. |
| 臺大學術典藏 |
2021-09-17T03:21:15Z |
Pulmonary granulomas: Give it a whorl
|
Keng L.-T.; Lo W.-Y.; Huang H.-N.; Ko H.-J.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-09-17T03:21:15Z |
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
|
SHENG-KAI LIANG; Hsu C.-C.; Song H.-L.; Huang Y.-C.; Kuo C.-W.; Yao X.; Li C.-C.; Yang H.-C.; Hung Y.-L.; Chao S.-Y.; Wu S.-C.; Tsai F.-R.; Chen J.-K.; Liao W.-N.; Cheng S.-C.; Tsou T.-C.; Wang I.-C. |
| 臺大學術典藏 |
2021-09-17T03:21:15Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
Keng L.-T.; SHENG-KAI LIANG; Tseng C.-P.; Wen Y.-F.; Tsou P.-H.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Lee M.-R.; Ko J.-C. |
| 臺大學術典藏 |
2021-07-29T03:09:26Z |
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
|
HSIANG-LIN SONG; SHENG-KAI LIANG; Chia-Chan Hsu; Yu-Chi Huang; CHUN-WEI KUO; Xiang Yao; Hui-Chen Yang; Yu-Ling Hung; Sheng-Yang Chao; Shun-Chi Wu; Feng-Ren Tsai; Jen-Kun Chen; Wei-Neng Liao; Shin-Chin Cheng; Tsui-Chun Tsou; I-Ching Wang |
| 臺大學術典藏 |
2021-07-21T23:21:17Z |
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
|
SHENG-KAI LIANG; Hsu, Chia Chan; HSIANG-LIN SONG; Huang, Yu Chi; CHUN-WEI KUO; Yao, Xiang; Li, Chien Cheng; Yang, Hui Chen; Hung, Yu Ling; Chao, Sheng Yang; Wu, Shun Chi; Tsai, Feng Ren; Chen, Jen Kun; Liao, Wei Neng; Cheng, Shin Chin; Tsou, Tsui Chun; Wang, I. Ching |
| 臺大學術典藏 |
2021-07-21T23:21:16Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
LI-TA KENG; SHENG-KAI LIANG; Tseng, Chi Ping; Wen, Yueh Feng; PING-HSIEN TSOU; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; MENG-RUI LEE; JEN-CHANG KO |
| 臺大學術典藏 |
2021-07-20T07:54:39Z |
Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy
|
LIH-YU CHANG; LI-TA KENG; Chin-Chung Shu; Jason Yao-Ping Chen; SHENG-KAI LIANG; Ching-Kai Lin; LIH-YU CHANG; CHIA-HAO CHANG; Jann-Yuan Wang; Chong-Jen Yu; Li-Na Lee |
| 臺大學術典藏 |
2021-07-14T07:15:22Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
JEN-CHUNG KO; LI-TA KENG; SHENG-KAI LIANG; PING-HSIEN TSOU; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; MENG-RUI LEE; Tseng, Chi-Ping ; Wen, Yueh-Feng |
| 臺大學術典藏 |
2021-07-14T07:15:21Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
JEN-CHUNG KO; PING-HSIEN TSOU; CHIEN-JEN CHANG; SHENG-KAI LIANG; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; LI-TA KENG; MENG-RUI LEE; Zong-Lin Lin ; Yu-Chiang Pan ; Hui-Chen Yang ; Yueh-Feng Wen ; Chia-Jung Liu ; Guan-Hua Huang and Yaw-Kuen Li |
| 臺大學術典藏 |
2021-04-21T23:30:28Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
PING-HSIEN TSOU; Lin, Zong Lin; Pan, Yu Chiang; Yang, Hui Chen; CHIEN-JEN CHANG; SHENG-KAI LIANG; Wen, Yueh Feng; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; Liu, Chia Jung; LI-TA KENG; MENG-RUI LEE; JEN-CHANG KO; Huang, Guan Hua; Li, Yaw Kuen |
| 臺大學術典藏 |
2021-03-11T08:34:25Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; MENG-RUI LEE; JEN-CHANG KO; SHENG-KAI LIANG; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-03-11T08:34:22Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan C.-H.;Chang Y.-F.;Lee M.-S.;Wen B.-C.;Jen-Chang Ko;Liang S.-K.;Liang M.-C.; Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; SHENG-KAI LIANG; Liang M.-C. |
| 臺大學術典藏 |
2021-03-11T08:34:21Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-03-11T08:34:19Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:34:18Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-03-11T08:34:15Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-03-09T08:07:35Z |
Pulmonary granulomas: Give it a whorl
|
WEI-YUNG LO; SHENG-KAI LIANG; LI-TA KENG; Hsien-Neng Huang , Huan-Jang Ko |
| 臺大學術典藏 |
2021-02-08T08:05:08Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu |
| 臺大學術典藏 |
2021-02-02T09:21:39Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen, Yueh Feng; MENG-RUI LEE; Yang, Ching Yao; JANN-YUAN WANG; JEN-CHUNG KO; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2021-01-19T12:08:48Z |
Pulmonary granulomas: Give it a whorl
|
LI-TA KENG; WEI-YUNG LO; Hsien-Neng Huang; Ko, Huan Jang; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-01-08T03:40:22Z |
Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii)
|
Hsueh P.-R.; Lee L.-N.; SHENG-KAI LIANG; Liao C.-H.; Huang Y.-T.; Lee M.-R.; Tsai H.-Y.; Cheng A.; Liu C.-Y. |
| 臺大學術典藏 |
2021-01-08T03:40:21Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; Ko J.-C.; SHENG-KAI LIANG; Liang M.-C. |
| 臺大學術典藏 |
2021-01-08T03:40:21Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
Lee M.-R.; Ko J.-C.; SHENG-KAI LIANG; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-08T03:40:21Z |
Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy
|
SHENG-KAI LIANG; Chen J.Y.P.; Shu C.-C.; Keng L.-T.; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-01-08T03:40:21Z |
Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014
|
Lee M.-R.; Tsai C.-J.; SHENG-KAI LIANG; Lin C.-K.; Huang Y.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Foxm1 Transcription Factor Regulates Lung Adenocarcinoma Development
|
SHENG-KAI LIANG; Chao S.-Y.; Li C.-C.; Ip K.-U.; Lin Y.-K.; Hsu C.-C.; Hsu P.-C.; Wang I.-C. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; Ho C.-C.; Liao W.-Y.; Lee M.-R.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Wang H.-C.; Hsu C.-L.; Jerng J.-S.; Chen Y.-F.; Chang H.-T.; Chen I.-C.; Cheng J.-C.; SHENG-KAI LIANG; Lin S.-Y.; Keng L.-T.; Chung K.-P.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Shih J.-Y.; Ko J.-C.; Lee M.-R.; Keng L.-T.; Hsieh M.-S.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-01-08T03:40:19Z |
Pulmonary granulomas: Give it a whorl
|
Keng L.-T.; Lo W.-Y.; Huang H.-N.; Ko H.-J.; SHENG-KAI LIANG |
